George W. LeMaitre, Chairman and CEO at LEMAITRE VASCULAR INC (LMAT), sold 192,712 shares at $75.30 ($14.6M) on 2024-05-08, disclosed to the SEC on 2024-05-08.
Scheduled sale ($14.6M) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.23 | 29,500 | $2.2M | 15.2% |
| 2 | $75.94 | 16,200 | $1.2M | 8.4% |
| 3 | $76.12 | 23,206 | $1.8M | 12.1% |
| 4 | $76.12 | 23,206 | $1.8M | 12.1% |
| 5 | $75.24 | 26,044 | $2.0M | 13.4% |
| 6 | $75.24 | 26,044 |
| $2.0M |
| 13.4% |
| 7 | $75.86 | 20,256 | $1.5M | 10.5% |
| 8 | $75.86 | 20,256 | $1.5M | 10.5% |
| 9 | $75.30 | 8,000 | $602K | 4.1% |
| Total | $75.64 avg | 192,712 | $14.6M | 100% |
| Filing → |
| LMAT | SELL | 2025-08-08 | $9.4M | — | Filing → |
| LMAT | SELL | 2025-05-20 | $16.3M | — | Filing → |
| LMAT | SELL | 2024-07-18 | $9.9M | — | Filing → |